Figure 1: Data of new drug approvals by the US FDA between 1998 and 2017[1],[2],[3],[4](a) Bar graph depicts new drugs (new molecular entities- chemicals and biological) approved by the US FDA for a period of two decades (1998–2017). The number of drugs approved during this period and later withdrawn or associated with postmarket safety events is depicted by bar graph and line graph, respectively. (b) The different types of toxicities associated with approved drugs in 1998–2017 are denoted
![Figure 1: Data of new drug approvals by the US FDA between 1998 and 2017<sup>[1],[2],[3],[4]</sup>(a) Bar graph depicts new drugs (new molecular entities- chemicals and biological) approved by the US FDA for a period of two decades (1998–2017). The number of drugs approved during this period and later withdrawn or associated with postmarket safety events is depicted by bar graph and line graph, respectively. (b) The different types of toxicities associated with approved drugs in 1998–2017 are denoted](articles/2020/52/6/images/Indian J Pharmacol_2020_52_6_505_309731_f1.jpg)